Our take on the latest news and views on data.

Relevant company news, articles, podcasts, and blog posts.

Recent Posts

We’re Back!

Ozmosi has been on a purpose-driven hiatus peppered with innovation, development and growth. In less than one year, we have...

Recent Tweets

$NVCR FDA grants approval for Novocure's Optune Lua® for treating Metastatic Non-Small Cell Lung Cancer.

More Info: https://pryzm.ozmosi.com/product/30156 $XBI $IBB $XPH $PPH

$BMEA Biomea Fusion will reveal lead clinical candidate BMF-650 during conference call and webcast on October 30 at 4:30 pm ET. Also discuss preclinical data on BMF-219 combined with GLP-1 RA therapy.

More Info: https://pryzm.ozmosi.com/product/23569 $XBI $IBB $XPH $PPH

$MRNS Marinus Pharmaceuticals enhances IP portfolio with method of treating patent for ZTALMY® dosing schedules.

More Info: https://pryzm.ozmosi.com/product/976 $XBI $IBB $XPH $PPH

Beacon Therapeutics reports encouraging 2-year results from Phase 2 SKYLINE study of AGTC-501 for X-linked Retinitis Pigmentosa patients.

More Info: https://pryzm.ozmosi.com/product/30454 $XBI $IBB $XPH $PPH

Load More

Get Started with OZMOSI

We synthesize and process insights, delivering what you need quickly, effectively, and efficiently.

600 Warren Ave,
Spring Lake, NJ 07762